Our results showed that NRP1, a transmembrane glycoprotein expressed in a wide variety of human cancers, and required for aggressive tumour growth and tumour-related angiogenesis (reviewed in ref. [49], is an important early player in PCa drug resistance and a putative candidate for its induction. Here, NRP1 is linked to posterior cortical atrophy.